Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab plus carboplatin + paclitaxel + bevacizumab vs pemetrexed + platinum in stage IV non-squamous NSCLC with EGFR or ALK alterations
KCT0004043Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of atezolizumab in Non-small cell lung cancer (NS-NSCLC), sponsored by Roche. Started Aug 2019; status: completed.
02
Drugs
atezolizumab
03
Conditions
Non-small cell lung cancer (NS-NSCLC)
Beyond the preview
Go deeper on KCT0004043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004043.